Although detected in patients with the subacute disease, plasma levels of SAA1(34-104) were higher in patients at the acute stage of Kawasaki disease and the peptide was no longer detectable upon resolution of the disease (96). This evidence concerns the gene SAA1 and Kawasaki disease.